France · Question · Question écrite
16733
Question 16733 — people with disabilities
Introduced
7 July 2026
Last action
—
Status
posée
Sponsors
—
Subjects
Discovery layer
Source updated
7 July 2026
Summary
Mr. Sébastien Saint-Pasteur draws the attention of the Minister Delegate to the Minister of Health, Families, Autonomy and Disabled People, responsible for autonomy and disabled people, to the follow-up that the Government intends to give to the favorable opinion given by the High Health Authority concerning the anticipated support for the digital medical device Poppins Clinical, intended to support dyslexic children aged 7 to 11 years old. This decision constitutes an important step forward for families affected by specific language and learning disorders. It opens the way to better recognition of digital therapeutic tools when they are evaluated, prescribed and integrated into a care pathway. Associations representing families affected by Dys disorders have highlighted the interest in such a development. There French Dys Federation particularly welcomed this step, recalling that the delays in accessing speech therapy remain particularly long in many territories and that families need complementary, accessible and supervised solutions. Other associations involved in supporting Dys children, such as Dyspraxique Mais Fantastique, have also relayed work on the journey of health of Dys children, demonstrating the importance of better documenting needs, disruptions and difficulties in accessing care. However, this development can only be fully useful if it is part of a clear articulation with the existing offer, in particular with speech therapists, whose role remains central in the diagnosis, monitoring and rehabilitation of the children concerned. Therapeutic digital tools cannot replace professionals, but can contribute to strengthening the continuity of care, supporting families between sessions and consolidating learning through regular practice. This requirement for complementarity is in line with the reservations expressed by scientific representatives of speech therapy, who underline the potential interest of these devices while calling for a rigorous evaluation of their efficiency. Dyslexic disorders, when not identified and supported early enough, can have significant consequences on learning, self-esteem, school careers, the child's mental health and family balance. As such, early care should not be viewed solely as an additional expense, but as an investment likely to prevent disruptions in the pathway. as well as greater human, social, educational and medico-social costs in the medium and long term. This approach is in line with the work carried out within the framework of the commission of inquiry into the failures of public policies for the management of mental health and disability, which highlighted the need to better integrate the logic of prevention, early intervention and avoided costs into public decision-making. He him therefore asks what timetable the Government intends to follow up on the favorable opinion of the High Health Authority, under what conditions the coverage of Poppins Clinical could be made effective and how it intends to guarantee that this type of digital innovation is fully articulated with the provision of care, particularly speech therapy. He also asks whether the Government intends to integrate, in the evaluation of these devices, a medico-economic approach based on avoided costs, in order to better measure the benefit of early care for children, families and the overall sustainability of the health system.
Machine translation from French. The official text remains authoritative.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.assemblee-nationale.fr/dyn/17/questions/QANR5L17QE16733
- Open data entity: https://www.assemblee-nationale.fr/dyn/opendata/QANR5L17QE16733